MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/pharmaceutics17101329

Медицинская библиотека · Pharmaceutics · 2025

Engineered Liposomal Delivery of Human ACE2 Across the Blood-Brain Barrier Attenuated Neurogenic Hypertension.

Shen Yue, Lamptey Richard Nii Lante, Mareddy Gowthami Reddy, Chaulagain Bivek, Singh Jagdish, Sun Chengwen

СтатьяПеревод пока не подготовлен

Аннотация

The blood-brain barrier (BBB) restricts the entry of therapeutic agents into the brain cardiovascular regulatory region, potentially contributing to drug-resistant hypertension.

Objective

The objective of this study was to overcome this limitation by modifying PEGylated liposomes with transferrin (Tf) to facilitate Tf receptor binding at the BBB and penetratin (Pen), a cell-penetrating peptide, to enhance neuronal uptake.

Methods

This study evaluated the efficacy of Tf-Pen-liposomes in delivering angiotensin-converting enzyme 2 (ACE2) or EGFP (control) genes across the BBB in rats. In addition, the therapeutic effect of intravenous administration of Tf-Pen-Lip carrying plasmid DNA encoding ACE2 (Tf-Pen-Lip-pACE2) was tested in a neurogenic hypertension model induced by intracerebroventricular (ICV) infusion of angiotensin II (Ang II) via osmotic pump implantation and brain cannulation.

Results

Conjugation with Tf and Pen significantly enhanced liposome-mediated gene transfection in cultured cells and increased transport across an in vitro BBB model. In vivo, intravenous administration of Tf-Pen-Lip-pACE2 or Tf-Pen-Lip-pGFP successfully elevated ACE2 or EGFP expression, respectively, in the hypothalamic paraventricular nucleus (PVN). Chronic ICV infusion of Ang II produced a sustained increase in blood pressure and heart rate, accompanied by sympathetic overactivation and elevated arginine vasopressin (AVP) secretion, hallmarks of neurogenic hypertension. Notably, intravenous Tf-Pen-Lip-pACE2 treatment dramatically attenuated Ang II-induced neurogenic hypertension, whereas Tf-Pen-Lip-pGFP had no effect on pressor responses, sympathetic activity, or AVP secretion.

Conclusions

This dual-functionalized liposomal delivery system effectively transported the ACE2 gene across the BBB into the brain, increased ACE2 expression, and markedly attenuated neurogenic hypertension following systemic administration.

Для цитирования: Shen Yue, Lamptey Richard Nii Lante, Mareddy Gowthami Reddy, Chaulagain Bivek, Singh Jagdish, Sun Chengwen. Engineered Liposomal Delivery of Human ACE2 Across the Blood-Brain Barrier Attenuated Neurogenic Hypertension.. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17101329.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.